# Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer

> **NCT00770354** · PHASE2 · TERMINATED · sponsor: **Antisoma Research** · enrollment: 110 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DRUG:** AS1402
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT00770354
- **Lead sponsor:** Antisoma Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2010-08
- **Final completion:** 2011-08
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2009-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770354, "Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00770354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*